Long-Term Aspirin Use Linked to Reduction in Liver Cancer Risk
WEDNESDAY, Oct. 10, 2018 -- Regular long-term aspirin use is associated with a dose-dependent reduction in the risk for hepatocellular carcinoma (HCC), according to a study published online Oct. 4 in JAMA Oncology.
Tracey G. Simon, M.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Aspirin | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Pharmaceuticals | Study | Urology & Nephrology